Switch theme
Sign up to access all valuation multiples
Max Healthcare Institute Ltd is a health care service provider. The company's facilities include third-party healthcare providers with whom the company has entered long-term service contracts for providing clinical, radiology, and pathology services. Its hospitals provide the full range of services through its Outpatient, Day Care, Emergency Room, and In-Patient departments to accommodate medical specialties such as orthopedics, internal medicine, general surgery, cardiac sciences, oncology, neurosciences, and obstetrics, as well as diagnostics. The group derives revenue from India.
2001
12.3K+
LTM Revenue $1.1B
LTM EBITDA $274M
$13.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Max Healthcare Institute has a last 12-month revenue (LTM) of $1.1B and a last 12-month EBITDA of $274M.
In the most recent fiscal year, Max Healthcare Institute achieved revenue of $823M and an EBITDA of $226M.
Max Healthcare Institute expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Max Healthcare Institute valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | XXX | $823M | XXX | XXX | XXX |
| Gross Profit | $791M | XXX | $650M | XXX | XXX | XXX |
| Gross Margin | 75% | XXX | 79% | XXX | XXX | XXX |
| EBITDA | $274M | XXX | $226M | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 27% | XXX | XXX | XXX |
| EBIT | $225M | XXX | $174M | XXX | XXX | XXX |
| EBIT Margin | 21% | XXX | 21% | XXX | XXX | XXX |
| Net Profit | $166M | XXX | $126M | XXX | XXX | XXX |
| Net Margin | 16% | XXX | 15% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $214M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Max Healthcare Institute's stock price is INR 1125 (or $13).
Max Healthcare Institute has current market cap of INR 1.09T (or $12.8B), and EV of INR 1.12T (or $13.1B).
See Max Healthcare Institute trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13.1B | $12.8B | XXX | XXX | XXX | XXX | $0.18 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Max Healthcare Institute has market cap of $12.8B and EV of $13.1B.
Max Healthcare Institute's trades at 16.9x EV/Revenue multiple, and 60.0x EV/EBITDA.
Equity research analysts estimate Max Healthcare Institute's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Max Healthcare Institute has a P/E ratio of 77.0x.
See valuation multiples for Max Healthcare Institute and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $12.8B | XXX | $12.8B | XXX | XXX | XXX |
| EV (current) | $13.1B | XXX | $13.1B | XXX | XXX | XXX |
| EV/Revenue | 12.4x | XXX | 16.9x | XXX | XXX | XXX |
| EV/EBITDA | 47.7x | XXX | 60.0x | XXX | XXX | XXX |
| EV/EBIT | 58.0x | XXX | 77.5x | XXX | XXX | XXX |
| EV/Gross Profit | 16.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | 77.0x | XXX | 102.1x | XXX | XXX | XXX |
| EV/FCF | -234.3x | XXX | 244.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMax Healthcare Institute's last 12 month revenue growth is 24%
Max Healthcare Institute's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $39K for the same period.
Max Healthcare Institute's rule of 40 is 53% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Max Healthcare Institute's rule of X is 87% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Max Healthcare Institute and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 24% | XXX | 38% | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 28% | XXX | XXX | XXX |
| EBITDA Growth | 26% | XXX | 34% | XXX | XXX | XXX |
| Rule of 40 | 53% | XXX | 53% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 87% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $39K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 58% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Max Healthcare Institute acquired XXX companies to date.
Last acquisition by Max Healthcare Institute was XXXXXXXX, XXXXX XXXXX XXXXXX . Max Healthcare Institute acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Max Healthcare Institute founded? | Max Healthcare Institute was founded in 2001. |
| Where is Max Healthcare Institute headquartered? | Max Healthcare Institute is headquartered in India. |
| How many employees does Max Healthcare Institute have? | As of today, Max Healthcare Institute has 12.3K+ employees. |
| Is Max Healthcare Institute publicy listed? | Yes, Max Healthcare Institute is a public company listed on BOM. |
| What is the stock symbol of Max Healthcare Institute? | Max Healthcare Institute trades under 543220 ticker. |
| When did Max Healthcare Institute go public? | Max Healthcare Institute went public in 2020. |
| Who are competitors of Max Healthcare Institute? | Similar companies to Max Healthcare Institute include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Max Healthcare Institute? | Max Healthcare Institute's current market cap is $12.8B |
| What is the current revenue of Max Healthcare Institute? | Max Healthcare Institute's last 12 months revenue is $1.1B. |
| What is the current revenue growth of Max Healthcare Institute? | Max Healthcare Institute revenue growth (NTM/LTM) is 24%. |
| What is the current EV/Revenue multiple of Max Healthcare Institute? | Current revenue multiple of Max Healthcare Institute is 12.4x. |
| Is Max Healthcare Institute profitable? | Yes, Max Healthcare Institute is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Max Healthcare Institute? | Max Healthcare Institute's last 12 months EBITDA is $274M. |
| What is Max Healthcare Institute's EBITDA margin? | Max Healthcare Institute's last 12 months EBITDA margin is 26%. |
| What is the current EV/EBITDA multiple of Max Healthcare Institute? | Current EBITDA multiple of Max Healthcare Institute is 47.7x. |
| What is the current FCF of Max Healthcare Institute? | Max Healthcare Institute's last 12 months FCF is -$55.8M. |
| What is Max Healthcare Institute's FCF margin? | Max Healthcare Institute's last 12 months FCF margin is -5%. |
| What is the current EV/FCF multiple of Max Healthcare Institute? | Current FCF multiple of Max Healthcare Institute is -234.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
